Cancer Science & Therapy

Precision Medicine in Targeting ROS1- Rearranged Non-small Cell Lung Cancer

Abstract

Yasar Ahmed, Dennehy C, Jordan E and Calvert P

Globally, lung cancer is the leading cause of death from cancer among men and women. The overall 5-year survival rate of lung cancer is around 16-19%. The emergence of targeted therapy and immunotherapy have changed the treatment paradigm of advanced NSCLC.